| Typicality: | 0.317 |
| Saliency: | 0.157 |
| as a phase iii trial | 2 | manner |
| trial → be published in → peer-reviewed journals | 5 |
| trial → be published in → peer-reviewed journal | 3 |
| negative | neutral | positive |
| 0.022 | 0.768 | 0.210 |
| Raw frequency | 8 |
| Normalized frequency | 0.157 |
| Modifier score | 0.500 |
| Perplexity | 8.683 |